Trial reportFrontiers in pharmacology2026
ED95 determination of continuous norepinephrine infusion for preventing spinal anesthesia-induced hypotension in obese parturients during cesarean delivery.
Trial report in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Norepinephrine is an effective vasopressor for preventing and managing spinal anesthesia-induced hypotension during cesarean delivery. Nevertheless, data regarding the 95% effective dose (ED Methods: This prospective dose-finding study enrolled parturients scheduled for elective cesarean delivery under spinal anesthesia. Participants were stratified into two groups based on body mass index (BMI): non-obese group (BMI <30 kg/m Results: Eighty parturients were included in the analysis. The ED Conclusion: The findings indicate that obese parturients require a significantly higher prophylactic dose of norepinephrine infusion to prevent spinal anesthesia-induced hypotension compared to the non-obese counterparts. These results underscore the importance of individualized dosing strategies based on BMI to optimize hemodynamic management in obese parturients undergoing cesarean delivery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.